Search Results - "Arlene M. Buller"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing by Pratt, Victoria M, Caggana, Michele, Bridges, Christina, Buller, Arlene M, DiAntonio, Lisa, Highsmith, W. Edward, Holtegaard, Leonard M, Muralidharan, Kasinathan, Rohlfs, Elizabeth M, Tarleton, Jack, Toji, Lorraine, Barker, Shannon D, Kalman, Lisa V

    Published in The Journal of molecular diagnostics : JMD (01-05-2009)
    “…The number of different laboratories that perform genetic testing for cystic fibrosis is increasing. However, there are a limited number of quality control and…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Secondary Mutation (c.94_95delAG) in A −α3.7 Allele Associated with Hb H Disease in Two Unrelated African American Individuals Homozygous for the −α3.7 Deletion (−α3.7/−α3.7T) by Zhao, Po, Buller-Burckle, Arlene M., Peng, Mei, Anderson, Alison, Han, Z. Jenny, Gallivan, Monica V.E.

    Published in Hemoglobin (01-02-2012)
    “…Hb H disease is rarely seen in individuals of African descent although α-thalassemia (α-thal) is common in this population. Usually α-thal is due either to…”
    Get full text
    Journal Article
  8. 8

    The Roles of 5′-HS2, 5′-HS3, and the γ-Globin TATA, CACCC, and Stage Selector Elements in Suppression of β-Globin Expression in Early Development by Thanh Giang Sargent, Charles C. DuBois, Arlene M. Buller, Joyce A. Lloyd

    Published in The Journal of biological chemistry (16-04-1999)
    “…The roles of HS2 and HS3 from the human β-globin locus control region and of the TATA, CACCC, and stage selector elements of the γ-globin promoter, in…”
    Get full text
    Journal Article
  9. 9

    The roles of 5'-HS2, 5'-HS3, and the gamma-globin TATA, CACCC, and stage selector elements in suppression of beta-globin expression in early development by Sargent, T G, DuBois, C C, Buller, A M, Lloyd, J A

    Published in The Journal of biological chemistry (16-04-1999)
    “…The roles of HS2 and HS3 from the human beta-globin locus control region and of the TATA, CACCC, and stage selector elements of the gamma-globin promoter, in…”
    Get full text
    Journal Article
  10. 10

    Secondary mutation (c.94_95delAG) in a -α3.7 allele associated with Hb H disease in two unrelated African American individuals homozygous for the -α(3.7) deletion (-α3.7/-α3.7T) by Zhao, Po, Buller-Burckle, Arlene M, Peng, Mei, Anderson, Alison, Han, Z Jenny, Gallivan, Monica V E

    Published in Hemoglobin (2012)
    “…Hb H disease is rarely seen in individuals of African descent although α-thalassemia (α-thal) is common in this population. Usually α-thal is due either to…”
    Get full text
    Journal Article
  11. 11

    A Combination of Hydroxyurea and Isobutyramide to Induce Fetal Hemoglobin in Transgenic Mice Is More Hematotoxic Than the Individual Agents by Buller, Arlene M, Elford, Howard L, DuBois, Charles C, Meyer, Joanne, Lloyd, Joyce A

    Published in Blood cells, molecules, & diseases (01-08-1999)
    “…Pharmacologic agents such as hydroxyurea (HU), N, 3–4 trihydroxybenzamide (didox), and isobutyramide (ISB) can elevate γ-globin as a potential treatment for…”
    Get full text
    Journal Article
  12. 12

    The gamma-globin promoter has a major role in competitive inhibition of beta-globin gene expression in early erythroid development by Sargent, T G, Buller, A M, Teachey, D T, McCanna, K S, Lloyd, J A

    Published in DNA and cell biology (01-04-1999)
    “…The human gamma-globin gene competitively inhibits beta-globin gene expression in early erythroid development. To identify the gamma-globin gene sequences…”
    Get more information
    Journal Article
  13. 13

    Genetic changes in solid tumors by Barcus, Mary E., Ferreira-Gonzalez, Andrea, Buller, Arlene M., Wilkinson, David S., Garrett, Carleton T.

    Published in Seminars in surgical oncology (01-06-2000)
    “…Although most solid tumors are treated surgically, determining the genetic changes present in the tumor of an individual patient is becoming increasingly…”
    Get full text
    Journal Article
  14. 14